Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.12.2023 | Seed | $2.44M | - |
Mentions in press and media 2
| Date | Title | Description |
| 14.12.2023 | Cadenza Bio Raises $2.44M Series Seed Funding | Cadenza Bio, an Oklahoma City, OK-based biotechnology company, raised $2.44M in Series Seed funding.
The round was led by Plains Ventures, with participation from the Oklahoma Life Science Fund, Cortado Ventures, Boyd Street Ventures, and I... |
| - | Cadenza Bio | “Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.” |
Reviews 0
